Champions Oncology CSBR
NASDAQ CSBR
$4.84 -0.06 (-1.22%)
As of: Oct 14, 2026 · 11:55 AM EDT

Champions Oncology (CSBR) Liabilities and Shareholders Equity (2011 - 2026)

Updated

Champions Oncology (CSBR) posted Liabilities and Shareholders Equity of $33.29 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), up 9.0% from $30.55 million a year earlier and up 23.3% from the prior quarter.

Analysis

Champions Oncology (CSBR) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends

At the end of FY2026 (ended Apr 30, 2026), Champions Oncology's Liabilities and Shareholders Equity came in at $26.99 million, down 16.6% from FY2025.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -0.4% (FY2021 to FY2026).
  • In prior fiscal years, Champions Oncology's Liabilities and Shareholders Equity was $32.34 million in FY2025 (+23.8%), $26.13 million in FY2024 (-23.8%), $34.31 million in FY2023 (-3.0%) and $35.38 million in FY2022 (+28.2%).
  • The fiscal Q1 2027 figure stands as the highest quarterly Liabilities and Shareholders Equity since fiscal Q4 2023.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in five of the last eight quarters, with growth averaging 6.8%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was fiscal Q3 2022, with growth of 33.0%; the weakest was fiscal Q3 2024, with a decline of 25.9%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior fiscal quarters was $26.99 million (Q4 2026), $28.45 million (Q3 2026) and $30.16 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Iqvia Holdings 43.61 Bn 35.31 Bn 1.44 Bn 29.88 Bn
2 Medpace Holdings 17.32 Bn 15.38 Bn 201.64 Mn 2.06 Bn
3 Charles River Laboratories International 14.52 Bn 13.72 Bn 363.37 Mn 7.53 Bn
4 Icon 13.20 Bn 10.31 Bn 479.29 Mn 16.40 Bn
5 Fortrea Holdings 2.04 Bn 1.42 Bn 139.20 Mn 2.71 Bn
6 Ginkgo Bioworks Holdings 725.88 Mn -36.20 Mn 18.44 Mn 990.05 Mn
7 Evotec SE 509.65 Mn -1.10 Bn - 1.80 Bn
8 Champions Oncology 67.26 Mn 42.35 Mn 7.70 Mn 33.29 Mn
9 MindWalk Holdings 65.40 Mn 29.05 Mn 1.61 Mn 12.36 Mn
10 Natural Alternatives International 6.69 Mn -21.39 Mn 1.73 Mn 126.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 33.29 Mn
Apr 30, 2026 26.99 Mn
Jan 31, 2026 28.45 Mn
Oct 31, 2025 30.16 Mn
Jul 31, 2025 30.55 Mn
Apr 30, 2025 32.34 Mn
Jan 31, 2025 30.63 Mn
Oct 31, 2024 25.24 Mn
Jul 31, 2024 24.93 Mn
Apr 30, 2024 26.13 Mn
Jan 31, 2024 26.79 Mn
Oct 31, 2023 28.29 Mn
Jul 31, 2023 29.91 Mn
Apr 30, 2023 34.31 Mn
Jan 31, 2023 36.15 Mn
Oct 31, 2022 36.36 Mn
Jul 31, 2022 34.39 Mn
Apr 30, 2022 35.38 Mn
Jan 31, 2022 33.58 Mn
Oct 31, 2021 29.30 Mn
API Access

Champions Oncology Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CSBR&period=max&api_key=YOUR_API_KEY